Gyre Therapeutics Inc. Cash Flow-to-Debt Ratio
Gyre Therapeutics Inc. cash flow-to-debt ratio. Gyre Therapeutics Inc. (GYRE) has a Cash Flow-to-Debt Ratio of 0.13x as of March 2026, meaning its operating cash flow of $3.18 Million could theoretically repay 0% of its total liabilities ($25.03 Million) in one year. Check GYRE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Gyre Therapeutics Inc. (2004–2025)
Cash flow-to-debt ratio of Gyre Therapeutics Inc. from 2004 to 2025. Historical debt coverage capacity for Gyre Therapeutics Inc. across 22 annual periods. Check how aggressively does Gyre Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Gyre Therapeutics Inc. Cash Flow-to-Debt Ratio by Year (2004–2025)
Gyre Therapeutics Inc. cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for Gyre Therapeutics Inc.. For the full cash flow conversion analysis, see cash efficiency ratio of Gyre Therapeutics Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $1.01 Million | $23.85 Million | ▲ +131.4% |
| 2024 | -0.13x | $-3.64 Million | $27.00 Million | ▼ -153.4% |
| 2023 | 0.25x | $25.89 Million | $102.59 Million | ▼ -70.4% |
| 2022 | 0.85x | $10.68 Million | $12.54 Million | ▲ +114.8% |
| 2021 | -5.75x | $-83.75 Million | $14.57 Million | ▼ -96.0% |
| 2020 | -2.93x | $-55.05 Million | $18.78 Million | ▼ -103.1% |
| 2019 | -1.44x | $-43.61 Million | $30.22 Million | ▲ +74.9% |
| 2018 | -5.74x | $-28.55 Million | $4.97 Million | ▼ -151.5% |
| 2017 | -2.28x | $-19.94 Million | $8.74 Million | ▼ -172.0% |
| 2016 | -0.84x | $-18.47 Million | $22.02 Million | ▼ -67.2% |
| 2015 | -0.50x | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $2.91 Million | ▼ -228.2% |
| 2013 | -3.61x | $-40.61 Million | $11.26 Million | ▲ +23.3% |
| 2012 | -4.70x | $-64.24 Million | $13.66 Million | ▼ -370.8% |
| 2011 | -1.00x | $-83.72 Million | $83.84 Million | ▼ -223.4% |
| 2010 | 0.81x | $138.30 Million | $170.94 Million | ▲ +934.6% |
| 2009 | -0.10x | $-24.27 Million | $250.39 Million | ▲ +85.9% |
| 2008 | -0.69x | $-28.26 Million | $41.18 Million | ▼ -230.9% |
| 2007 | 0.52x | $24.84 Million | $47.38 Million | ▲ +186.7% |
| 2006 | -0.60x | $-9.89 Million | $16.37 Million | ▼ -338.6% |
| 2005 | -0.14x | $-26.25 Million | $190.48 Million | ▲ +0.3% |
| 2004 | -0.14x | $-25.04 Million | $181.17 Million | — |